PMA supplement
P250033 S002: NEXUS Aortic Arch Stent Graft System
FDA PMA supplement · Normal 180 Day Track No User Fee · Endospan, Ltd.
Key facts
| Original PMA | P250033 |
|---|---|
| Supplement number | S002 |
| Supplement type | Normal 180 Day Track No User Fee |
| Reason for the supplement | Postapproval Study Protocol |
| Trade name | NEXUS Aortic Arch Stent Graft System |
| Generic name | Endovascular System for Treatment of Ascending Aorta and Aortic Arch Lesions |
| Applicant | Endospan , Ltd. |
| Product code | SDZ |
| Received date | Apr 30, 2026 |
| Decision date | Jul 24, 2026 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: